Tirzepatide
Dual GLP-1 and GIP receptor agonist.
Compounded tirzepatide online · English & SpanishTirzepatide
Compounded tirzepatide · dose personalized to you
From $225/4 weeks
$1,350 upfront for 24 weeks
Tirzepatide acts on both GIP and GLP-1 receptors involved in appetite and fullness. A licensed provider reviews your history, discusses approved options and decides whether a compounded preparation fits your medical needs.
REMEVi offers its compounded GLP-1 program in 49 states and Washington, DC. It is not available in Louisiana. Your provider must be licensed in the state where you receive care.
See If You Qualify Not sure? See all plans and pricingYour provider determines whether treatment is right for you. Your price every 4 weeks stays the same at every dose.
- No insurance required
- Licensed U.S. providers
- Pharmacies we name
- Founded by patients
- Fast, discreet shipping
- Unlimited follow-up with your clinician
$0 Membership fees
Quick answers
How much does REMEVi cost?
| Medication | 24-week plan | 12-week plan | Every 4 weeks |
|---|---|---|---|
| Tirzepatide injection | $225 per 4 weeks | $233 per 4 weeks | $269 per 4 weeks |
Your price never goes up: same at every dose and every renewal of your plan. No membership fee. Compounded medications are not FDA-approved.
What’s included in the price?
Your plan price includes the clinician evaluation and follow-up, the medication if it is prescribed, injection or dosing supplies, shipping, the GLP-1 lab tests your clinician requires, and care coordination in English or Spanish. The health questionnaire is free, and there is no separate membership fee.
Where is REMEVi available?
REMEVi’s GLP-1 program is available in 49 states and Washington, DC. It is not available in Louisiana. Care happens online, so there is no clinic to visit, and medication ships to your door. The clinician who reviews your questionnaire must be licensed in the state where you receive care. See the state-by-state list.
Can I do everything in Spanish?
Yes. The intake questionnaire, the clinical evaluation, your dosing instructions, the patient portal, billing, and our care coordinators and support are all available in Spanish. You choose English or Spanish when you start, and you can switch languages at any time.
Who prescribes, and which pharmacy fills it?
Clinicians in the OpenLoop network who are licensed in your state review your questionnaire and decide whether a prescription is appropriate. If one is prescribed, a state-licensed US 503A compounding pharmacy prepares it: RedRock Pharmacy (Utah), Health Warehouse (Kentucky), Precision Medicine (New York) or Triad Rx (Alabama). See our pharmacy partners. Compounded medications are not FDA-approved.
How long until my medication ships?
Median 3.6 days from payment to shipment (1.9–7.0 days for the middle half of orders; 33 orders, July–September 2026). The pharmacy order was placed a median of 0.7 days after payment (41 orders). Carrier delivery time comes after shipment. Your timing can differ.
Your medication.
And the care around it.
One program price, with no separate membership fee or increase for a higher prescribed dose.
See every payment option and full costThe monthly plan is billed every 4 weeks. The 12-week and 24-week plans are prepaid for the full term, with the total charge shown before you choose. Review the renewal terms at checkout and in your patient portal.
- Clinical evaluation
- Your history, medications, goals and suitability reviewed by a licensed provider.
- Prescribed medication
- If approved, your individual prescription is filled through the pharmacy network.
- Follow-up & required labs
- Lab tests required by your clinician for the GLP-1 program are included in your plan price.
- Shipping & bilingual support
- Shipments every four weeks, plus care coordination in English and Spanish.
What is compounded tirzepatide — and is it safe?
A compounded medicine is prepared by a pharmacy for an individual prescription. It is not FDA-approved or an approved generic of a brand medicine. The FDA does not review compounded drugs for safety, effectiveness and quality before they are marketed.
Clinical review and pharmacy oversight matter, but neither guarantees the safety of a preparation. Ask why an approved medicine cannot meet your medical needs and which pharmacy will dispense your prescription.
How it works
Built to keep signalling long after a meal.
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Receptors sit in the brain, gut and pancreas, where activation supports appetite regulation and metabolic function.
Activates GLP-1 and GIP receptors
Tirzepatide is a dual agonist: it acts on both of the gut-hormone receptors that signal fullness, rather than GLP-1 alone.
Signals satiety for days, not minutes
The GLP-1 your gut makes is broken down by the DPP-4 enzyme within minutes. A receptor agonist is engineered to keep signalling long enough for once-weekly dosing.
Slows gastric emptying
Food leaves the stomach more gradually, which extends the feeling of fullness after a meal and is also why dose titration matters for tolerability.
The evidence
What the trials actually measured.
Tirzepatide in SURMOUNT-1.
The trial studied tirzepatide with lifestyle support in 2,539 adults with obesity or overweight without diabetes. At 15 mg, average weight loss was 20.9%, versus 3.1% with placebo, using the treatment-regimen estimand. This was not a study of REMEVi compounded medication.
20.9% Average body-weight reduction in this trial
72 weeks Trial duration
Source: Jastreboff et al. SURMOUNT-1. NEJM 2022. DOI: 10.1056/NEJMoa2206038.
Follow the prescribed schedule.
The approved injectable medicine is given once weekly. Your compounded prescription has its own concentration and instructions. Confirm the milligram dose and syringe units with your pharmacy; do not calculate a dose from another product’s label.
Weekly Injection schedule, when prescribed
Your label Your preparation’s instructions
Source: Zepbound prescribing information; FDA unapproved GLP-1 safety information.
Dose changes are clinical decisions.
Your clinician considers response, side effects and medical history before increasing a dose. An individual titration schedule does not, by itself, establish that a compounded preparation is medically necessary or legally eligible for compounding.
Individual Schedule set by your prescriber
Stay in touch Discuss side effects before changing dose
Source: FDA compounding guidance; REMEVi dose-level catalog.
Plan for follow-up, not a promised milestone.
Weight management may involve ongoing treatment and support. Discuss benefit, tolerability, cost and a plan for stopping or changing treatment with your clinician. Trial averages do not predict how much weight you will lose or how quickly.
Ongoing Review of benefit and tolerability
No guarantee Individual outcomes vary
Source: Zepbound prescribing information; SURMOUNT-1.
These trials studied the manufacturers’ medicines, not compounded preparations. They do not establish equivalence, safety or effectiveness for REMEVi’s compounded medication.
How REMEVi works
Care from your first question through your next refill.
See If You Qualify
A licensed provider decides whether treatment is appropriate — nobody is prescribed automatically.
-
Step 1Medical intake
Start the free health questionnaire. Choose a plan and review the full charge before authorizing payment.
About 2 minutes -
Step 2Clinician review
A licensed provider in your state reviews your intake and prescribes only if it is clinically appropriate.
Timing depends on your review -
Step 3Pharmacy and shipping
A named, state-licensed pharmacy fills your prescription and ships it cold-chain in discreet packaging.
3–5 business days to dispatch after approval, then two-day shipping -
Step 4Follow-up, in your language
Message your care team as often as you need for dose adjustments and side-effect support, in English or Spanish.
Unlimited, every month
A live visit or additional clinical information may be required. Preparation, dispatch and delivery estimates are not guarantees.
Tirzepatide dosing protocol
Once-weekly subcutaneous injection, using only the dose and instructions on your prescription. These are REMEVi’s listed protocol levels, not the dosing schedule for a branded product.
Your provider may adjust the dose about every four weeks if appropriate. Not everyone progresses through every level. Do not change syringe units, frequency or dose yourself.
Level 12.125 mgStarting level
Level 24.25 mgOnly as prescribed
Level 36.375 mgOnly as prescribed
Level 48.5 mgOnly as prescribed
Level 511.125 mgOnly as prescribed
Tirzepatide results timeline
A care plan can have checkpoints. It cannot promise a weight-loss deadline.
Starting treatment
Review administration, storage, nutrition and possible side effects. Appetite response and tolerability vary.
During dose changes
Keep your clinician informed about symptoms and progress. Faster increases do not guarantee better results.
Long-term follow-up
Review benefit, tolerability and goals together. The trial results above are averages for the manufacturers’ medicines over 68 or 72 weeks, not a six-month promise for compounded treatment.
Before you start,
talk through the risks.
Read the approved medicine’s safety informationTell your clinician about a personal or family history of medullary thyroid carcinoma or MEN 2, pregnancy or pregnancy plans, severe stomach problems, pancreatitis, gallbladder disease and all medicines you take. The approved medicines carry a boxed warning about thyroid C-cell tumors.
The Zepbound label advises switching oral contraceptives to a non-oral method or adding a barrier method for four weeks after starting and four weeks after each dose increase. Discuss contraception with your clinician.
Nausea, vomiting, diarrhea and constipation can occur. Severity and duration vary. Seek medical attention for severe persistent abdominal pain, inability to keep fluids down or a serious allergic reaction. Review your full history and other medicines with your prescriber.
This is not the complete risk list. Safety information for approved medicines does not establish the safety of a compounded preparation.
Explore other treatments
Semaglutide
Once-weekly GLP-1 injection.
View treatment
Oral semaglutide
Daily tablet for needle-free dosing.
View treatment
NAD+ injections
Provider-led NAD+ information and options.
View treatment
Sermorelin
Stimulates the pituitary's own growth hormone.
View treatment
Glutathione
Antioxidant support against oxidative stress.
View treatmentCare you can check.
REMEVi offers its compounded GLP-1 program in 49 states and Washington, DC. It is not available in Louisiana. Your provider must be licensed in the state where you receive care.
Named pharmacies and license lookups
Check REMEVi’s LegitScript listing
Tirzepatide care in Las Vegas · Online visits; no clinic visit required.
Tirzepatide questions answered
What is tirzepatide and how does it work?
Tirzepatide acts on both GIP and GLP-1 receptors involved in appetite and fullness. A licensed provider reviews your history, discusses approved options and decides whether a compounded preparation fits your medical needs.
Is compounded tirzepatide FDA-approved?
No. Compounded medicines are not FDA-approved, are not approved generics of brand medicines and are not established as equivalent. Discuss approved options and the specific medical reason for compounding with your clinician. A prescription or pharmacy license does not establish FDA approval.
What are common side effects?
Nausea, vomiting, diarrhea and constipation can occur. Severity and duration vary. Seek medical attention for severe persistent abdominal pain, inability to keep fluids down or a serious allergic reaction. Review your full history and other medicines with your prescriber.
How long does tirzepatide take to work?
There is no guaranteed timeline or amount of weight loss. The cited trials measured averages over many months using the manufacturers’ medicines, not REMEVi compounded preparations. Your clinician monitors response and tolerability before changing treatment.
Can I use tirzepatide long-term?
Your clinician reviews whether continuing treatment is appropriate based on benefits, risks, tolerability and goals. Plan follow-up and discuss any decision to stop or switch. Do not combine semaglutide and tirzepatide or convert doses yourself.
What will I pay, and can I cancel?
$1,350 upfront for 24 weeks; $699 upfront for 12 weeks; $269 billed every 4 weeks. You can cancel future renewals without a cancellation fee. Prepaid terms are paid in advance; refund eligibility is governed by the Cancellation & Refund Policy.
What is included in care?
Clinical evaluation, prescribed medication if approved, shipping, ongoing follow-up and bilingual care coordination are included. Lab tests required by your clinician for the GLP-1 program are included in your plan price.
Your next step starts
with a conversation.
Tirzepatide · $1,350 upfront for 24 weeks
See if I qualifyFree questionnaire. No card to start. Prescription only if clinically appropriate.
Cancellation and refund policyThe GLP-1 Guide · Free
Not ready to start today? Take the guide with you.
What GLP-1 is, how it works, what to expect, and nutrition tips — in English and Spanish. Free, straight to your inbox.
Medically reviewed by Linda West-Conforti, RN · CA RN #389453 ·
Educational information; not individual medical advice.
Tirzepatide$1,350 upfront for 24 weeksSee if I qualify